BGC1614
BGC1614 is a Nectin-4-targeting bicyclic toxin conjugate (BTC) belonging to the category of peptide-drug conjugates (PDCs). BGC1614 exhibits strong targeted binding ability to Nectin-4, with an KD of 3.859 × 10-7 M. BGC1614 exhibits superior antitumor efficacy in nude mice bearing PC-3 and N87 tumor xenografts. BGC1614 can be used for research related to Nectin-4-overexpressing tumors (such as prostate cancer, gastric cancer).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C387H582N94O104S7
- 분자량:8439.78
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:PC-3 or N87 cells were implanted into nude mice[1]
-
Dosage:1.0, 3.0 mg/kg
-
Administration:i.v., once a week, 21 days
-
Result:Achieved tumor growth inhibition (TGI) rates of 96.3% in nude mice bearing PC-3 tumor xenografts.
Achieved tumor growth inhibition (TGI) rates of 41.9% and 70.1% respectively in nude mice bearing N87 tumor xenografts.
Showed no significant changes in body weight.
Chemical Information
-
분자량 8439.78
-
화학식 C387H582N94O104S7
-
Sequence
Mpa-Pro-Nal-(DAsp)-Cys-Met-hArg-Asp-Trp-Ser-Thr-Pro-HyP-Trp-Cys(TATA covalent with Mpa1,Cys5,Cys15)-Sar10-PEG6-Lys(Lys(N3)-(DBCO-PEG6-βAla-Sar10-Ala-hArg-Asp-Cys-Hyp-Leu-Val-Asn-Pro-Leu-Cys-Leu-His-Pro-(DAsp)-Trp-hArg-Cysteamine, TATA covalent with Cys15,Cys22,Cysteamine 29)-GA-Val-Cit-PABC-MMAE
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)